Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Molecular insight into how MRSA is becoming increasingly dangerous.

Otto M.

Virulence. 2012 Oct 1;3(6):521-3. doi: 10.4161/viru.21523. No abstract available.

2.

Pulmonary infections and community associated methicillin resistant Staphylococcus aureus: a dangerous mix?

Shilo N, Quach C.

Paediatr Respir Rev. 2011 Sep;12(3):182-9. doi: 10.1016/j.prrv.2010.10.007. Review.

PMID:
21722847
3.

Global epidemiology of community-associated methicillin resistant Staphylococcus aureus (CA-MRSA).

Mediavilla JR, Chen L, Mathema B, Kreiswirth BN.

Curr Opin Microbiol. 2012 Oct;15(5):588-95. doi: 10.1016/j.mib.2012.08.003. Review.

PMID:
23044073
4.

[Methicillin resistance in Staphylococcus aureus: emergence and molecular basis].

Nour M, Mastouri M, Ben Nejma M.

Pathol Biol (Paris). 2005 Jul;53(6):334-40. Review. French.

PMID:
16004945
5.

New type of protective hybrid and nanocomposite hybrid coatings containing silver and copper with an excellent antibacterial effect especially against MRSA.

Šlamborová I, Zajícová V, Karpíšková J, Exnar P, Stibor I.

Mater Sci Eng C Mater Biol Appl. 2013 Jan 1;33(1):265-73. doi: 10.1016/j.msec.2012.08.039.

PMID:
25428071
6.

Multilocus sequence typing and the evolution of methicillin-resistant Staphylococcus aureus.

Robinson DA, Enright MC.

Clin Microbiol Infect. 2004 Feb;10(2):92-7. Review.

7.

No Outbreak of Vancomycin and Linezolid Resistance in Staphylococcal Pneumonia over a 10-Year Period.

Yayan J, Ghebremedhin B, Rasche K.

PLoS One. 2015 Sep 23;10(9):e0138895. doi: 10.1371/journal.pone.0138895.

9.

[Combat dogs--dangerous dogs].

Eichelberg H.

Dtsch Tierarztl Wochenschr. 2000 Mar;107(3):91-3. German.

PMID:
10774065
10.

Antibiotic resistance in Staphylococcus aureus: concerns, causes and cures.

Chopra I.

Expert Rev Anti Infect Ther. 2003 Jun;1(1):45-55. Review.

PMID:
15482101
11.

The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA).

Enright MC, Robinson DA, Randle G, Feil EJ, Grundmann H, Spratt BG.

Proc Natl Acad Sci U S A. 2002 May 28;99(11):7687-92.

12.

The standard one gram dose of vancomycin is not adequate prophylaxis for MRSA.

Catanzano A, Phillips M, Dubrovskaya Y, Hutzler L, Bosco J 3rd.

Iowa Orthop J. 2014;34:111-7.

13.

MRSA as a cause of lung infection including airway infection, community-acquired pneumonia and hospital-acquired pneumonia.

Defres S, Marwick C, Nathwani D.

Eur Respir J. 2009 Dec;34(6):1470-6. doi: 10.1183/09031936.00122309. Review.

15.

Characteristics of methicillin resistant Staphylococcus aureus isolated from chicken meat and hospitalized dogs in Korea and their epidemiological relatedness.

Kwon NH, Park KT, Jung WK, Youn HY, Lee Y, Kim SH, Bae W, Lim JY, Kim JY, Kim JM, Hong SK, Park YH.

Vet Microbiol. 2006 Oct 31;117(2-4):304-12.

PMID:
16806746
16.

Linezolid for the treatment of methicillin-resistant Staphylococcus aureus infections in children.

Kaplan SL, Afghani B, Lopez P, Wu E, Fleishaker D, Edge-Padbury B, Naberhuis-Stehouwer S, Bruss JB.

Pediatr Infect Dis J. 2003 Sep;22(9 Suppl):S178-85.

PMID:
14520144
17.

Genome and virulence determinants of high virulence community-acquired MRSA.

Baba T, Takeuchi F, Kuroda M, Yuzawa H, Aoki K, Oguchi A, Nagai Y, Iwama N, Asano K, Naimi T, Kuroda H, Cui L, Yamamoto K, Hiramatsu K.

Lancet. 2002 May 25;359(9320):1819-27.

PMID:
12044378
18.

[Community-associated methicillin-resistant Staphylococcus aureus--molecular evolution, characteristics and significance].

Budimir A, Kalenić S.

Lijec Vjesn. 2007 Oct-Nov;129(10-11):355-63. Review. Croatian.

PMID:
18257337
19.

Clinical and molecular epidemiology of methicillin-resistant Staphylococcus aureus in New Zealand: rapid emergence of sequence type 5 (ST5)-SCCmec-IV as the dominant community-associated MRSA clone.

Williamson DA, Roberts SA, Ritchie SR, Coombs GW, Fraser JD, Heffernan H.

PLoS One. 2013 Apr 25;8(4):e62020. doi: 10.1371/journal.pone.0062020.

20.

Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Europe.

Otter JA, French GL.

Lancet Infect Dis. 2010 Apr;10(4):227-39. doi: 10.1016/S1473-3099(10)70053-0. Review.

PMID:
20334846
Items per page

Supplemental Content

Support Center